Literature DB >> 21674589

Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.

Michael K Axthelm1, Dennis N Bourdette, Gail H Marracci, Weiping Su, Elizabeth T Mullaney, Minsha Manoharan, Steven G Kohama, Jim Pollaro, Ellen Witkowski, Paul Wang, William D Rooney, Lawrence S Sherman, Scott W Wong.   

Abstract

OBJECTIVE: To describe Japanese macaque encephalomyelitis (JME), a spontaneous inflammatory demyelinating disease occurring in the Oregon National Primate Research Center's (ONPRC) colony of Japanese macaques (JMs, Macaca fuscata).
METHODS: JMs with neurologic impairment were removed from the colony, evaluated, and treated with supportive care. Animals were humanely euthanized and their central nervous systems (CNSs) were examined.
RESULTS: ONPRC's JM colony was established in 1965 and no cases of JME occurred until 1986. Since 1986, 57 JMs spontaneously developed a disease characterized clinically by paresis of 1 or more limbs, ataxia, or ocular motor paresis. Most animals were humanely euthanized during their initial episode. Three recovered, later relapsed, and were then euthanized. There was no gender predilection and the median age for disease was 4 years. Magnetic resonance imaging of 8 cases of JME revealed multiple gadolinium-enhancing T(1) -weighted hyperintensities in the white matter of the cerebral hemispheres, brainstem, cerebellum, and cervical spinal cord. The CNS of monkeys with JME contained multifocal plaque-like demyelinated lesions of varying ages, including acute and chronic, active demyelinating lesions with macrophages and lymphocytic periventricular infiltrates, and chronic, inactive demyelinated lesions. A previously undescribed gamma-herpesvirus was cultured from acute JME white matter lesions. Cases of JME continue to affect 1% to 3% of the ONPRC colony per year.
INTERPRETATION: JME is a unique spontaneous disease in a nonhuman primate that has similarities with multiple sclerosis (MS) and is associated with a novel simian herpesvirus. Elucidating the pathogenesis of JME may shed new light on MS and other human demyelinating diseases.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674589      PMCID: PMC3170450          DOI: 10.1002/ana.22449

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  26 in total

1.  Epstein-Barr virus and multiple sclerosis.

Authors:  A Ascherio; M Munch
Journal:  Epidemiology       Date:  2000-03       Impact factor: 4.822

2.  Chronic experimental allergic encephalomyelitis in monkeys.

Authors:  A FERRARO; C L CAZZULLO
Journal:  J Neuropathol Exp Neurol       Date:  1948-07       Impact factor: 3.685

3.  Multiple sclerosis. Animal model:Theiler's virus infection in mice.

Authors:  M C Dal Canto; H L Lipton
Journal:  Am J Pathol       Date:  1977-08       Impact factor: 4.307

Review 4.  Creation of a model for multiple sclerosis in Callithrix jacchus marmosets.

Authors:  C P Genain; S L Hauser
Journal:  J Mol Med (Berl)       Date:  1997-03       Impact factor: 4.599

5.  Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.

Authors:  P Diaz-Villoslada; A Shih; L Shao; C P Genain; S L Hauser
Journal:  J Neuroimmunol       Date:  1999-09-01       Impact factor: 3.478

6.  Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis.

Authors:  D R Carrigan; D Harrington; K K Knox
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

Review 7.  Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Vaccine       Date:  2010-09-16       Impact factor: 3.641

8.  The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study.

Authors:  Niklas K U Koehler; Claude P Genain; Barbara Giesser; Stephen L Hauser
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

9.  Active human herpesvirus 6 infection in patients with multiple sclerosis.

Authors:  Roberto Alvarez-Lafuente; Carlos Martín-Estefanía; Virginia de Las Heras; Carmen Castrillo; Juan José Picazo; Eduardo Varela de Seijas; Rafael Arroyo González
Journal:  Arch Neurol       Date:  2002-06

10.  ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS.

Authors:  T M Rivers; F F Schwentker
Journal:  J Exp Med       Date:  1935-04-30       Impact factor: 14.307

View more
  25 in total

1.  Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.

Authors:  Maria Teresa Ferrò; Diego Franciotta; Alessandro Prelle; Arabella Bestetti; Paola Cinque
Journal:  J Neurovirol       Date:  2012-05-19       Impact factor: 2.643

2.  Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.

Authors:  Nicholas E Martinez; Fumitaka Sato; Eiichiro Kawai; Seiichi Omura; Robert P Chervenak; Ikuo Tsunoda
Journal:  Future Virol       Date:  2012-06       Impact factor: 1.831

3.  Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis.

Authors:  Tiffany C Blair; Minsha Manoharan; Stephanie D Rawlings-Rhea; Ian Tagge; Steven G Kohama; Julie Hollister-Smith; Betsy Ferguson; Randall L Woltjer; Meredith C Frederick; James Pollaro; William D Rooney; Larry S Sherman; Dennis N Bourdette; Scott W Wong
Journal:  J Neuroimmunol       Date:  2015-12-02       Impact factor: 3.478

4.  Correction of refractive errors in rhesus macaques (Macaca mulatta) involved in visual research.

Authors:  Jude F Mitchell; Chantal J Boisvert; Jon D Reuter; John H Reynolds; Mathias Leblanc
Journal:  Comp Med       Date:  2014-08       Impact factor: 0.982

5.  Genomic characterization of Japanese macaque rhadinovirus, a novel herpesvirus isolated from a nonhuman primate with a spontaneous inflammatory demyelinating disease.

Authors:  Ryan D Estep; Scott G Hansen; Kelsey S Rogers; Michael K Axthelm; Scott W Wong
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 6.  Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.

Authors:  Gerda B Toth; Csanad G Varallyay; Andrea Horvath; Mustafa R Bashir; Peter L Choyke; Heike E Daldrup-Link; Edit Dosa; John Paul Finn; Seymur Gahramanov; Mukesh Harisinghani; Iain Macdougall; Alexander Neuwelt; Shreyas S Vasanawala; Prakash Ambady; Ramon Barajas; Justin S Cetas; Jeremy Ciporen; Thomas J DeLoughery; Nancy D Doolittle; Rongwei Fu; John Grinstead; Alexander R Guimaraes; Bronwyn E Hamilton; Xin Li; Heather L McConnell; Leslie L Muldoon; Gary Nesbit; Joao P Netto; David Petterson; William D Rooney; Daniel Schwartz; Laszlo Szidonya; Edward A Neuwelt
Journal:  Kidney Int       Date:  2017-04-20       Impact factor: 10.612

7.  The different clinical effects of anti-BLyS, anti-APRIL and anti-CD20 antibodies point at a critical pathogenic role of γ-herpesvirus infected B cells in the marmoset EAE model.

Authors:  S Anwar Jagessar; Zahra Fagrouch; Nicole Heijmans; Jan Bauer; Jon D Laman; Luke Oh; Thi Migone; Ernst J Verschoor; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-19       Impact factor: 4.147

Review 8.  Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis.

Authors:  Bert A 't Hart
Journal:  Primate Biol       Date:  2019-05-10

Review 9.  Viruses and multiple sclerosis.

Authors:  Jussi Oskari Virtanen; Steve Jacobson
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-08       Impact factor: 4.388

10.  Japanese Macaque Rhadinovirus Encodes a Viral MicroRNA Mimic of the miR-17 Family.

Authors:  Rebecca L Skalsky; Sarah A Barr; Andrew J Jeffery; Tiffany Blair; Ryan Estep; Scott W Wong
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.